BACK TO CONTENTS   |    PDF   |    PREVIOUS   |    NEXT


Title

Molecular Docking Analysis of Pyrimethamine Derivatives with Plasmodium falciparum Dihydrofolate Reductase

 

Authors

Indra Vikram Singh & Sanjay Mishra*

 

Affiliation

Laboratory of Bioinformatics, Department of Biotechnology, IFTM University, Delhi Road (NH 24), Moradabad 244 102, Uttar Pradesh, India;

 

Email

sanjaymishra@iftmuniversity.ac.in

 

Article Type

Hypothesis

 

Date

Received May 12, 2018; Revised May 23, 2018; Accepted May 23, 2018; Published May 31, 2018

 

Abstract

DHFR from Pf is a known target for malaria. There is a continued effort for the design and development of the potent inhibitor for PfDHFR in the control of malaria. Therefore it is of interest to screen PfDHFR with the derivatives of Pyrimethamine. The results show that the compound CID 10476801 has lowest docked energy (-11.48 kcal/mol) with protein likely to be a drug candidate, probably inhibiting PfDHFR structure. Residues of PfDHFR protein involved in the formation of hydrogen bonds with compound CID 10476801 are confirmed to be ASP54. The findings provide new insights into development of potent chemotherapeutic drug for combating malaria.

 

Keywords

Analogues, Antifolate, Antimalarial, de novo, DHFR, inhibitors, Plasmodium falciparum, resistance, quadruple mutant, validated targets

 

Citation

Singh & Mishra. Bioinformation 14(5): 232-235 (2018)

 

Edited by

P Kangueane

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.